Vials of tirzepatide 2.5 mg and 5 mg will be available with a prescription for the labeled drug through LillyDirect after completing a multistep verification process, the company said.
Lauren Biscaldi, MS
Advertisement
Articles by Lauren Biscaldi, MS
The monthly out of pocket cap applies to all BI inhalers and goes into effect on June 1, 2024.
The new app is designed to help persons with diabetes understand how food and activity impact blood glucose levels and to revise behavior accordingly.
For Episodic Migraine, Both OTC and New Oral Prescription Medications Provide Meaningful Pain Relief
In episodic migraine, both traditional oral OTC medications and newly approved classes led to significantly better improvements in pain compared with placebo.
Advertisement
Latest Updated Articles
For Episodic Migraine, Both OTC and New Oral Prescription Medications Provide Meaningful Pain ReliefPublished: September 21st 2023 | Updated:
Abbott, WeightWatchers Announce App Integrating FreeStyle Libre 2 CGM DataPublished: September 22nd 2023 | Updated:
Boehringer Ingelheim Will Cap Out of Pocket Costs for Inhalers at $35 per MonthPublished: March 7th 2024 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
2
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks
3
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
4
Topline Real-World Data Show Fezolinetant Improves VMS, Sleep, and Work Productivity in Women With Confirmed Menopausal VMS
5
